--Company Announces Receipt of FDA Complete Response Letter (CRL) for Generic Advair Diskus® Product; Based on Preliminary Review, Company Expects At Least a Second Review Cycle--
PR Newswire
TREVOSE, Pa., March 4, 2022
PR Newswire
TREVOSE, Pa., March 4, 2022
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey